Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S J Ireland

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Progress in Medicinal Chemistry|January 1, 1992
Ondansetron and related 5-HT3 antagonists: recent advancesA W Oxford, J A Bell, G J Kilpatrick, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|June 3, 1998
Subtle neurological deficits and psychopathological findings in substance-abusing homeless and non-homeless veteransR Douyon, P Guzman, G Romain, et al.
Journal of Substance Abuse Treatment|January 1, 1994
A description of the Maternal Addiction Program of the University of Miami/Jackson Memorial Medical CenterR M Malow, S J Ireland, E S Halpert, et al.
European Journal of Pharmacology|June 19, 1987
Effect of the 5-HT3 receptor antagonist, GR38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brainR M Hagan, A Butler, J M Hill, et al.
British Journal of Pharmacology|June 1, 1991
Receptors mediating tachykinin-induced contractile responses in guinea-pig tracheaS J Ireland, F Bailey, A Cook, et al.
Journal of Medicinal Chemistry|July 1, 1990
Potent and highly selective neurokinin antagonistsP Ward, G B Ewan, C C Jordan, et al.
Neuropeptides|June 1, 1991
Receptor-selective, peptidase-resistant agonists at neurokinin NK-1 and NK-2 receptors: new tools for investigating neurokinin functionR M Hagan, S J Ireland, C C Jordan, et al.
Journal of Animal Science|April 1, 1991
Influence of zeranol and breed on growth, composition of gain, and plasma hormone concentrationsJ E Williams, S J Ireland, T A Mollett, et al.
British Journal of Pharmacology|November 1, 1990
The pharmacological characterization of 5-HT3 receptors in three isolated preparations derived from guinea-pig tissuesA Butler, C J Elswood, J Burridge, et al.
Neuropeptides|December 1, 1994
GR138676, a novel peptidic tachykinin antagonist which is potent at NK3 receptorsJ M Stables, I J Beresford, S Arkinstall, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Progress in Medicinal Chemistry|January 1, 1992
Ondansetron and related 5-HT3 antagonists: recent advancesA W Oxford, J A Bell, G J Kilpatrick, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|June 3, 1998
Subtle neurological deficits and psychopathological findings in substance-abusing homeless and non-homeless veteransR Douyon, P Guzman, G Romain, et al.
Journal of Substance Abuse Treatment|January 1, 1994
A description of the Maternal Addiction Program of the University of Miami/Jackson Memorial Medical CenterR M Malow, S J Ireland, E S Halpert, et al.
European Journal of Pharmacology|June 19, 1987
Effect of the 5-HT3 receptor antagonist, GR38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brainR M Hagan, A Butler, J M Hill, et al.
British Journal of Pharmacology|June 1, 1991
Receptors mediating tachykinin-induced contractile responses in guinea-pig tracheaS J Ireland, F Bailey, A Cook, et al.
Journal of Medicinal Chemistry|July 1, 1990
Potent and highly selective neurokinin antagonistsP Ward, G B Ewan, C C Jordan, et al.
Neuropeptides|June 1, 1991
Receptor-selective, peptidase-resistant agonists at neurokinin NK-1 and NK-2 receptors: new tools for investigating neurokinin functionR M Hagan, S J Ireland, C C Jordan, et al.
Journal of Animal Science|April 1, 1991
Influence of zeranol and breed on growth, composition of gain, and plasma hormone concentrationsJ E Williams, S J Ireland, T A Mollett, et al.
British Journal of Pharmacology|November 1, 1990
The pharmacological characterization of 5-HT3 receptors in three isolated preparations derived from guinea-pig tissuesA Butler, C J Elswood, J Burridge, et al.
Neuropeptides|December 1, 1994
GR138676, a novel peptidic tachykinin antagonist which is potent at NK3 receptorsJ M Stables, I J Beresford, S Arkinstall, et al.
Pageof 4